Looking to reduce timeline of your quest to launch medical devices? Looking to get this done at right price? Watch out for this fully integrated medical device CRO

We are referring CSSi Lifescience’s recently launched medical device CRO. The fully integrated medical device CRO is here impact timelines of regulatory clearance and increase profitability of medtech OEMs, both big and small.

Claims of the company are backed by 250+ filed 510K submissions. CSSi Lifescience provides end to end services and beyond, it assists medical device OEMs in design development, testing, clinical studies and reimbursement.

About Company:

CSSi LifeSciences™ Drug & Medical Device Commercialization & Medical Device CRO Our goal is to ensure a successful and expeditious pathway to commercialization for our clients’ drugs and medical devices by providing insight-driven analysis that saves time, development costs, and resources. We enable faster, more informed decision making to increase commercial success, while reducing the risk of late-stage failures and post-authorization action. Unparalleled Success from Discovery to Commercialization • Commercialized over 500 new drugs, biologics, medical devices and in-vitro diagnostics • Over 250 medical device 510(k) Class 1-3 submissions with 100% success. • Extensive Orphan, “First in Class,” and “First In” Indication success. • Reduced time to approval by over 600 days. • Over 100 NDA, ANDA and BLA submissions, with 96% success. • Greater than 60 EMA CHMP Marketing Authorizations. • SmartStudyTM design and feasibility assessments enhanced study efficiency and success and reduced protocol amendments by over 50%. CSSi LifeSciences™ Medical Device CRO has experience navigating regulations in over 100 countries. Often companies struggle with the pathways for a medical device from design to commercialization because of the ambiguity and complexity of the process. Regulations and requirements change frequently and vary by notifying bodies, country, level of risk (i.e., Class 1-3), specific product claims, and intended use. Our diverse team has many years of medical device commercialization experience, with knowledge that goes beyond published guidance, documents and initiatives. CSSi LifeSciences™ Medical Device CRO aims to impact the timeline of regulatory clearance and increase profitability.


Medical Device Commercialization, Clinical study planning and design, Global Regulatory filing and Representation, Preclinical and clinical studies, Quality Management Systems, CRO, Medical Devices


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s